Building solid partnerships across a variety of expertise plays a significant role in the development of our product pipeline and enables us to better serve consumers and healthcare providers who need and rely on our treatments.
From our inception, HRA Pharma has developed solid relationships with partners over the long term. We enter into these partnerships with integrity, respect and transparency and with the shared goal of developing innovative, effective, quality treatments and services.
It is our privilege to count amongst our partners pharmaceutical companies, public and private institutions, healthcare professionals, the scientific community and service providers. Moreover, our experienced business development team is constantly on the lookout for new opportunities and partnerships.
The science of innovation via collaboration
From an internal point of view, HRA Pharma brings to the table clinical expertise and experience in product development, regulatory matters, marketing and supply chain capabilities. We are adept at launching new brands on a global scale and at understanding the needs of both patients and consumers.
We are able to leverage our size and adapt quickly to the needs of our partners. We are agile and skilled in doing so. Our wealth of experience and flexibility when structuring deals, for example, has enabled us to maximize the value of our portfolio via in-licensing and out-licensing agreements. We currently market both proprietary and in–licensed products in parts of Europe, and out-license our products to marketing partners in other areas of the world.
We are able to set up joint clinical trials, co-marketing and co-promotional programs.
Innovative partnerships and new opportunities
Thanks to our comprehensive business model, we are able to navigate with precision and skill our highly regulated industry and stay one step ahead. We strive to innovate and, as such, we are constantly driving forward to identify drugs and solutions with meaningful benefits for our customers. Our focus is on innovative added value consumer healthcare products. Within the next several years, we plan to leverage our strong operational, development and regulatory capabilities as well as our solid experience in innovative Rx-to-OTC switches to launch on the market novel pharmaceutical brands that have the potential to become leaders in attractive self-care categories.
In the meantime, we are constantly working to identify and capitalise on new market opportunities that best fit our capabilities. Whether this means enhancing our existing skills or acquiring new ones, addressing new customers’ needs or developing new products ourselves, we are focused on pursuing high-value opportunities that we are strongly positioned to win and develop.
Developing strategic partnerships is a key ingredient for us to achieve our dream of empowering people throughout the world with innovative, added value, self-care solutions and making them as accessible as possible.
Spotting new opportunities using our insight
At HRA Pharma, we have a dedicated in-house team whose function is to search, screen and secure in-licensing opportunities. Consumer healthcare is the field in which we project to grow both organically and through targeted acquisitions of products or projects that will strengthen and complement our product portfolio.